Vikas S. Sridhar

974 total citations · 1 hit paper
55 papers, 483 citations indexed

About

Vikas S. Sridhar is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, Vikas S. Sridhar has authored 55 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Surgery and 7 papers in Nephrology. Recurrent topics in Vikas S. Sridhar's work include Diabetes Treatment and Management (35 papers), Pancreatic function and diabetes (17 papers) and Diabetes Management and Research (16 papers). Vikas S. Sridhar is often cited by papers focused on Diabetes Treatment and Management (35 papers), Pancreatic function and diabetes (17 papers) and Diabetes Management and Research (16 papers). Vikas S. Sridhar collaborates with scholars based in Canada, United States and Netherlands. Vikas S. Sridhar's co-authors include David Z.I. Cherney, Jacinthe Boulet, Atit Dharia, Abid Ali Khan, Patrick R. Lawler, Michel White, Nadia Bouabdallaoui, Jean‐Claude Tardif, Hongyan Liu and Yuliya Lytvyn and has published in prestigious journals such as Diabetes Care, Diabetes and Journal of the American Society of Nephrology.

In The Last Decade

Vikas S. Sridhar

47 papers receiving 478 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammation in heart failure: pathophysiology and therapeutic strategies

2024 47 citations Jacinthe Boulet, Vikas S. Sridhar et al. Inflammation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vikas S. Sridhar Canada	13	274	160	97	84	59	55	483
Yufeng Li China	10	316 1.2×	86 0.5×	154 1.6×	53 0.6×	74 1.3×	28	445
Hardik Vasnawala India	8	168 0.6×	140 0.9×	62 0.6×	37 0.4×	33 0.6×	12	408
Noboru Kurinami Japan	11	293 1.1×	124 0.8×	136 1.4×	47 0.6×	31 0.5×	24	440
Keizo Kajiwara Japan	11	270 1.0×	115 0.7×	136 1.4×	47 0.6×	35 0.6×	30	432
Aaron Y. Kluger United States	9	231 0.8×	114 0.7×	107 1.1×	42 0.5×	63 1.1×	17	364
Soner Cander Türkiye	10	160 0.6×	90 0.6×	63 0.6×	24 0.3×	39 0.7×	71	345
Tomio Jinnouchi Japan	15	363 1.3×	161 1.0×	145 1.5×	56 0.7×	33 0.6×	38	591
Meha Sharma India	10	263 1.0×	122 0.8×	120 1.2×	20 0.2×	26 0.4×	65	446
Shinichiro Shirabe Japan	8	299 1.1×	72 0.5×	96 1.0×	57 0.7×	13 0.2×	20	400
Vlado Perkovic Australia	4	592 2.2×	176 1.1×	161 1.7×	129 1.5×	55 0.9×	14	813

Countries citing papers authored by Vikas S. Sridhar

Since Specialization

Citations

This map shows the geographic impact of Vikas S. Sridhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas S. Sridhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas S. Sridhar more than expected).

Fields of papers citing papers by Vikas S. Sridhar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas S. Sridhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas S. Sridhar. The network helps show where Vikas S. Sridhar may publish in the future.

Co-authorship network of co-authors of Vikas S. Sridhar

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas S. Sridhar. A scholar is included among the top collaborators of Vikas S. Sridhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas S. Sridhar. Vikas S. Sridhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sridhar, Vikas S., et al.. (2026). Next-generation therapeutics for diabetic kidney disease. Nature Reviews Nephrology.

Sridhar, Vikas S., et al.. (2026). Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial. Circulation Heart Failure. 19(3). e013054–e013054.

Jongs, Niels, Peter J. Greasley, Cecilia Karlsson, et al.. (2025). Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial. Diabetes Obesity and Metabolism. 27(8). 4415–4426. 1 indexed citations

Hwang, Boeun, et al.. (2025). Bioengineering Approaches to In Vitro Modeling of Genetic and Acquired Cardiac Diseases. Current Cardiology Reports. 27(1). 72–72. 3 indexed citations

Cadena, Melissa, Vikas S. Sridhar, Morteza Mahmoudi, et al.. (2025). Protocol for 3D bioprinting of a 3D in vitro model of neuroblastoma. STAR Protocols. 6(2). 103725–103725.

Gill, John S., Vikas S. Sridhar, Elizabeth Hendren, et al.. (2025). Could a simple flick of the switch increase deceased donor kidney utilization?. American Journal of Transplantation. 26(2). 246–248.

Sridhar, Vikas S., Ayodele Odutayo, Thomas Danne, et al.. (2024). Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD. Journal of the American Society of Nephrology. 36(5). 890–900. 5 indexed citations

Boulet, Jacinthe, Vikas S. Sridhar, Nadia Bouabdallaoui, Jean‐Claude Tardif, & Michel White. (2024). Inflammation in heart failure: pathophysiology and therapeutic strategies. Inflammation Research. 73(5). 709–723. 47 indexed citations breakdown →

Sridhar, Vikas S., Francesco Cosentino, Samuel Dagogo‐Jack, et al.. (2024). Effects of ertugliflozin on uric acid and gout‐related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CV. Diabetes Obesity and Metabolism. 26(11). 5336–5346. 3 indexed citations

10.

Sridhar, Vikas S., Manuel López Mendoza, David Z.I. Cherney, et al.. (2024). Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications. Clinical Kidney Journal. 18(1). sfae370–sfae370. 2 indexed citations

11.

Nardone, Massimo, Kevin Yau, Ayodele Odutayo, et al.. (2024). Upcoming drug targets for kidney protective effects in chronic kidney disease. Nephrology Dialysis Transplantation. 40(Supplement_1). i47–i58. 2 indexed citations

12.

Azhie, Amirhossein, Eunice Xiang‐Xuan Tan, Vikas S. Sridhar, et al.. (2024). Glucagon‐like peptide ‐1 receptor agonists and sodium‐glucose cotransporter ‐2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients. Diabetes Obesity and Metabolism. 26(10). 4261–4272. 5 indexed citations

13.

Sridhar, Vikas S., Brendon L. Neuen, Robert A. Fletcher, et al.. (2023). Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials. Diabetes Obesity and Metabolism. 25(8). 2331–2339. 5 indexed citations

14.

Darshi, Manjula, Vikas S. Sridhar, Viktor R. Drel, et al.. (2023). 12-OR: Urine Lactate Is a Disease Biomarker for Diabetic Kidney Disease. Diabetes. 72(Supplement_1). 2 indexed citations

15.

Sridhar, Vikas S., Christine P. Limonte, Per‐Henrik Groop, et al.. (2023). Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes. Diabetologia. 67(1). 3–18. 17 indexed citations

16.

Sridhar, Vikas S., Hiddo J.L. Heerspink, Michael J. Davies, et al.. (2023). The Effects of Sotagliflozin in Type 1 Diabetes on Clinical Markers Associated With Cardiorenal Protection: An Exploratory Analysis of inTandem3. Diabetes Care. 46(7). e133–e135. 7 indexed citations

17.

Sridhar, Vikas S., et al.. (2021). Cardiorenal Protection in Diabetic Kidney Disease. Endocrinology and Metabolism. 36(2). 256–269. 12 indexed citations

18.

Sridhar, Vikas S., Habib Rahman, & David Z.I. Cherney. (2020). What have we learned about renal protection from the cardiovascular outcome trials and observational analyses with SGLT2 inhibitors?. Diabetes Obesity and Metabolism. 22(S1). 55–68. 19 indexed citations

19.

Laprise, Claudie, Vikas S. Sridhar, Lori J. West, et al.. (2017). Sex and gender considerations in transplantation research: protocol for a scoping review. Systematic Reviews. 6(1). 186–186. 6 indexed citations

20.

Sridhar, Vikas S., et al.. (2012). Acute community acquired Aspergillus pneumonia in a presumed immunocompetent host. BMJ Case Reports. 2012. bcr0920114866–bcr0920114866. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact